Veniti, Inc. (Veniti), is a growing medical device company focused on treating chronic venous disease. The Veniti platform will offer clinicians the first multi-product company solely focused on venous disease, including a vapor-based endovenous ablation system, a vena cava filter anchoring technology, and a venous stent system.
Employees: 11-50
Total raised: $30.5M
Investors 1
| Date | Name | Website |
| 17.07.2021 | Baird Capi... | bairdcapit... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.03.2015 | - | $17M | - |
| 08.03.2011 | Series A | $13.5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 10.03.2015 | Veniti Closes over $17M Equity and Debt Financing | Veniti, Inc., a St. Louis, MO-based medical device company, closed on an equity and debt financing totaling over $17m. The equity portion, its Series C, was led by previous investors Baird Capital and Tekla Healthcare and Tekla Life Science... |
| 10.03.2015 | Baird Capital Portfolio Company VENITI Raises $17 Million in Funding | - |
| 09.03.2011 | Veniti Raises $13.5M in Series A Financing | Veniti, Inc., a St. Louis, Mo.-based medical device company focused on the development of innovative solutions for the comprehensive treatment of chronic venous insufficiency (a condition that affects up to 20% of all U.S. adults), has rais... |
| 08.03.2011 | Veniti Secures $13.5 Million Series A Financing | Concurrent with this investment, Veniti will augment its product portfolio by acquiring two separate medical device companies, Varix Medical Corporation (Sunnyvale, CA) and Teneo Medical Development (Fremont, CA). The Veniti platform will o... |